North American Bronchodilator Market Size, Share, Forecast, Analysis, Industry Report to 2025.
North American
long-acting bronchodilator market was $1.5 billion in 2018 and is anticipated
to grow at a substantial rate of 2.0% during the forecast period. The major
factors that are contributing significantly to the market growth include rising
air pollution, growing geriatric population, and high healthcare expenditure.
The US and Canada are the major economies of North America. The rising
prevalence of chronic respiratory diseases, increasing geriatric population,
and technological advancement are the major factors augmenting the growth of
the long-acting bronchodilator market in North America. The increasing demand
for long-acting bronchodilator due to increasing COPD and asthma patients in
the US have endorsed the approval of cohesive reimbursement policies in the US,
is further fueling the growth of the market. The US is the major market due to
greater healthcare expenditure and a higher prevalence rate of respiratory
diseases.
Request
a Free Sample of our Report North American
Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/north-american-long-acting-bronchodilator-market
The North American
long-acting bronchodilator market is segmented on the basis of route of
administration, application, and end-user. Based on the route of administration,
the market is classified into oral, nasal, parenteral, and inhalation.
Moreover, on the basis of application, the market has been classified into
asthma and COPD diseases. The asthma disease application segment dominated the
regional market in 2018 and is further estimated to follow the same trend over
the forecast period. This is mainly due to the high prevalence of asthma in the
economies of the region such as the US and Canada. According to the Centers for
Disease Control and Prevention (CDC) 2017, there are around 26 million
asthmatics in the US, among which, nearly 18.9 million are adults and 7.1
million are children. In addition, based on the end-user, homecare and
hospitals and clinics have been analyzed.
A full Report of North American Long-Acting
Bronchodilator Market is
Available at: https://www.omrglobal.com/industry-reports/north-american-long-acting-bronchodilator-market
North American Long-Acting
Bronchodilators Market Segmentation
By Route of
Administration
·
Oral
·
Nasal
·
Parental
·
Inhalation
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
US
·
Canada
Company Profiles
·
Adamis Pharmaceuticals Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
GlaxoSmithKline PLC
·
Novartis AG
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-long-acting-bronchodilator-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Contact
no: +1 646-755-7667, +91 7803040404
Comments
Post a Comment